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Abstract
Background: To analyze the 10-year experience of single chamber permanent epicardial pacemaker placement for
children with congenital heart diseases (CHD) after surgical repair.
Methods: Between 2002 and 2014, a total of 35 patients with CHD (age: 26.9 ± 23.2 months, weight: 9.7 ± 5.6 kg)
received permanent epicardial pacemaker placement following corrective surgery. Echocardiography and
programming information of the pacemaker, as well as major adverse cardiac events (MACE) as heart failure or
sudden death, were recorded during follow-up (46.8 ± 33.8 months).
Results: Acute ventricular stimulation threshold was 1.34 ± 0.72 V and no significant increase was observed at the
last follow-up as 1.37 ± 0.81 V (p = 0.93). Compared with initial pacemaker implantation, the last follow-up didn’t
show significant increases in impedance (p = 0.327) or R wave (p = 0.635). Four patients received pacemaker
replacement because of battery depletion. 7/35 (20 %) of patients experienced MACE. Although the age and body
weight were similar between patients with and without MACE, the patients with MACE were with complex CHD
(100 % vs.55.6 %, p = 0.04).
Conclusion: High-degree iatrogenic atrioventricular block was the primary reason for placement of epicardial
pacemaker for patients with CHD after surgical repair. Pacemaker placement with the steroid-eluting leads results in
acceptable outcomes, however, the pacemaker type should be optimized for the children with complex CHD.
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Background
Permanent epicardial pacemaker have been utilized in
clinical practice for several decades and the numbers of
patients who require them are increasing. Pediatric
pacemaker implants comprise < 1 % of all pacemaker im-
plantations [1]. The main indication for permanent pace-
maker implantation in children is high-degree congenital
atrioventricular block (AVB) with a frequency of about 1/
2000 [2, 3]. Another important indication is high-degree
AVB following open-heart surgery, occurring with an inci-
dence of 1 %. It is the main reason for placement of
permanent epicardial pacemaker after congenital heart
surgery [4]. Although endocardial pacemaker have several
advantages, such as longer battery life, better sensing and
pacing thresholds, epicardial pacemakers are more suit-
able for infants and younger children who are still under
somatic growth, especially for patients with complicated
cardiac deformities [5, 6]. However, epicardial pacemakers
are less durable and have a higher incidence of complica-
tions as compared to endocardial pacemakers [7]. With
the development of steroid-eluting leads appears to offer a
better alternative to epicardial pacemaker. Its performance
and longevity have been demonstrated to be comparable
with the conventional endocardial leads [8].
Because of low economic statuses and undeveloped in-
surance systems, the single chamber pacemakers are uti-
lized in many heart center for sick children in China.
The current study aimed to review and analyze our 10-
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year experience in placement of single chamber perman-
ent epicardial pacemaker and its mid-term outcomes.
Methods
Patient characteristics
A total of 44 CHD patients aged < 8 years received
placement of epicardial pacemakers between 2002 and
2014 in our hospital. Nine children were excluded be-
cause they were associated with congenital AVB and
pacemaker was implanted during the surgical repair.
Thirty-five patients received permanent pacemaker im-
plantation for the iatrogenic AVB (age: 26.9 ±
23.2 months, weight: 9.7 ± 5.6 kg). The study was ap-
proved by the ethics committee of Fuwai Hospital. Pa-
tient data were reviewed retrospectively. The diagnoses
of CHD were summarized in Table 1 and all the patients
received the primary corrective operation.
Implantation procedure
All procedures were performed under general anaesthe-
sia. Steroid-eluting bipolar epicardial pacing leads were
inserted into the diaphragmatic surface of the right ven-
tricular free wall through the previous median sternot-
omy, and then connected to the plus generator within
the subrectus pocket. The patients received pacemaker
placement at 26 ± 3.1 days post-operation.
Pacemaker parameters and pacing mode
Acute ventricular stimulation threshold, impedance, R
wave, and pacing mode were recorded at implantation
and at the last follow-up.
Echocardiographic assessment
Left ventricular ejection fraction (LVEF) and left ven-
tricular end diastolic diameter (LVEDD) were recorded
at pre-implantation (1 week before pacemaker implant-
ation), post-implantation (1 week after pacemaker im-
plantation), and the last follow-up.
Follow-up
The duration of follow-up was 46.8 ± 33.8 months. Pace-
maker device-related complications were collected, in-
cluding lead failure, elevated pacing threshold, poor
sensing, and pocket infection. Age, body weight and type
of cardiac deformities were compared between patients
with and without major adverse cardiac events (MACE),
which included heart failure or sudden death.
Statistical analysis
Statistical calculations were carried out using SPSS ver-
sion 19.0. Continuous data were presented as mean ±
standard deviation or median and range. Categorical
data were expressed as frequency and percentage. The
independent sample t-test and one way analysis of vari-
ance were performed to compare the normally distrib-
uted variables when variances were homogeneous. If
variances are not homogeneous, Dunnett’s T3 test would
be performed. For categorical data, a comparison was
performed using the Chi-square test and Fisher’s exact
test. The Kaplan-Meier method was used to study the
battery longevity and patients survival curve. A P-value
lower than 0.05 was considered statistically significant.
Results
Early postoperative results
The operation time for pacemaker implantation (skin to
skin time) was 119.1 ± 33.5 min. After surgery, 11 pa-
tients were extubated in the operation room and the rest
were extubated within 4.8 h (range, 1.2–66 h). No blood
transfusions occurred in the perioperative period. Except
for a patient that suffered early postoperative death, who
died from the low cardiac output syndrome after surgi-
cal repair for complex congenital heart disease, all pa-
tients were discharged from the hospital.
Device characteristics
All the patients received a single chamber pacemaker
with VVI pacing mode. The mode wasn’t changed dur-
ing follow-up. Table 2 reported the data for ventricular
stimulation threshold, impedance, and R wave.
Echocardiographic findings
Compared with the post-operation, LVEF was significantly
decreased in the last follow-up (65.6 ± 5.3 % vs. 59.6 ±
7.6 %, p = 0.03), while a significant increase was observed
in LVEDD (25.5 ± 8.4 mm vs. 33.3 ± 9.6 mm, p = 0.005).
Figure 1 depicts the tendency of LVEF and LVEDD at pre-
operation, post-operation, and the last follow-up.
Follow-up
Four patients underwent pacemaker replacement at
50.8 months (range, 30–80 months) post-surgery due to
battery depletion. No pocket infection or lead fracture
occurred. Freedom from generator replacement was
94.1, 86.9, 77.2 and 61.8 % at 30, 36, 48, 57 months,
respectively.
7/35 (20 %) of patients experienced MACE as heart
failure or sudden death. Among them, four patients
suffered from heart failure, with cardiac deformities of
double outlet right ventricle (n = 2) and complete
endocardial cushion defect (n = 2). Their conditions
were improved after standard drug treatment. The
Table 1 Patient diagnoses
ccTGA DORV TECD TOF VSD ASD Total
Iatrogenic AVB 8 6 4 4 11 2 35
ccTGA corrected transposition of great arteries, DORV double outlet right
ventricle, TECD complete endocardial cushion defect, TOF tetralogy of Fallot,
VSD ventricular septal defect, ASD atrial septal defect
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other three patients suffered from sudden death at 6,
8, and 9 months post-operation, with cardiac deform-
ities of complete transposition of great arteries (n = 1),
double outlet right ventricle (n = 1), and tetralogy of
Fallot (n = 1). The average age and weight of patients
with MACE were 21.6 ± 30.66 months and 9.5 ±
6.4 kg, respectively. For patients without MACE, aver-
age age and weight were 20.4 ± 22 months and 9.8 ±
5.3 kg. There was no significant differences in age
and body weight between patients with and without
MACE (p > 0.05). But the type of cardiac deformities
in patients with MACE were complex CHD (100 %
vs.55.6 %, p = 0.046). Survival analysis of the patients
is presented in Fig. 2.
Discussion
CHD has become the leading type of birth defect in
China. However, potential iatrogenic AVB is inevitable in
a surgical operation and may result in postoperative
pacemaker implantation. In our center, the primary rea-
son for permanent pacemaker placement for children
with CHD was iatrogenic AVB after congenital heart
surgery. The most common type of cardiac deformities
in patients with iatrogenic AVB is ventricle septal defect,
followed by corrected transposition of great arteries
(ccTGA), which was consistent with other developing
counties such as Brazil and Egypt [9]. But in western
countries, the most common type was complete trans-
position of the great arteries with ventricular septal de-
fect, followed by complete endocardial cushion defect
[10]. It is possibly because the surgeons in these coun-
tries prefer to perform corrective surgery on younger
children with these two cardiac deformities, which could
lead to a higher incidence of iatrogenic AVB.
For postoperative iatrogenic AVB, it is generally ac-
knowledged that the proper duration of observation
before permanent pacemaker placement is 7–14 days
[11, 12]. However, in China, it is difficult for the patient’s
family to accept postoperative pacemaker implantation,
therefore, the observation time was extended, usually up
to 3 weeks. Surgical placement of epicardial pacemaker
is commonly known as the first choice for children with
iatrogenic AVB who are younger than 4 years old, espe-
cially for the patient with complicated cardiac deform-
ities, such as single ventricle and ccTGA.
Table 2 Analysis of the data for ventricular stimulation threshold, impedance, and R wave
Intraoperation Last follow-up P value
Ventricular stimulation threshold(V) 1.34 ± 0.72 1.37 ± 0.81 p = 0.933
Impedance (Ω) 366.7 ± 88.0 331.9 ± 95.9 p = 0.327
R wave(mV) 12.3 ± 3.5 11.4 ± 4.9 p = 0.635
Fig. 1 The tendency of LVEF and LVEDD at pre-implantation, post-
implantation and the last follow-up: a Left ventricular ejection
fraction:*p = 0.03. b Left ventricular end diastolic diameter:*p = 0.005
Fig. 2 Estimated Kaplan-Meyer survival curve, which included the
early mortality after pacemaker implantation
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All of our patients were implanted with a steroid-eluting
lead. Compared with the traditional non-steroid-eluting
lead, it could significantly reduce inflammation, with a low
sensing threshold and is more durable [13, 14]. During
follow-up, we didn’t observe a significant increase in the
ventricular stimulation threshold, impedance, or R wave.
Generally speaking, children have a higher heart rate
than adults, so their pulse generator is frequently
exhausted earlier because of high pacing rates. In the pa-
tient less than 19 years old who had received permanent
pacemaker implantation, it was reported that the mean
longevity of the pacemaker generator was 5.5 years, and
the lead was 10.8 years [6]. In the present study, no lead
fracture was recorded, but four patients underwent re-
operation for generator change because of battery
depletion.
Although all patients’ cardiac functions were within
the normal range (LVEF > 55 % is considered as normal
[15]), the last follow-up examination showed significant
decreases in LVEF compared with the post-operation
examination. The major reason could be the pacing
mode. Studies have shown that epicardial right ventricu-
lar free wall pacing could result in pathologic left ven-
tricular dilatation and dysfunction, which could do harm
to the patient’s cardiac functions [16, 17]. The significant
risk factor for the development of LV dilatation and dys-
function was the presence of epicardial RV free wall
pacing. One cross-sectional multicenter study showed
that LV pacing especially apical and lateral wall pacing
were associated with the best preservation of LV func-
tion, which appears to be related to preserved mechan-
ical synchrony and contraction efficiency [15]. Surgical
access to the LV is possible through the left lateral
thoracotomy [18], therefore, the pacing site could be op-
timized in the future study.
Twenty percent of patients in our study had MACE as
heart failure or sudden death. All these patients were iat-
rogenic AVB following complex congenital heart surgery.
These patients received a single chamber pacemaker.
Currently, dual chamber pacing systems are the first
choice for pediatric patients in western countries, but
single chamber pacing systems are still widely used in
China. It is no doubt that dual chamber pacing is better
than single chamber pacing, because it more closely re-
sembles cardiac physiology [19]. Therefore, with im-
provements in the public health insurance system, for
the complex CHD patient who suffered from iatrogenic
AVB after surgical repair, dual chamber pacing may re-
duce morbidity from heart failure and sudden death.
Conclusion
In summary, iatrogenic AVB following congenital heart
surgery is the primary reason for the placement of per-
manent pacemaker in CHD patients. The epicardial
approach for permanent pacemaker implantation pro-
vided acceptable outcomes for iatrogenic AVB. However,
for the complex CHD patient with iatrogenic AVB, the
pacemaker type should be optimized.
Abbreviations
ASD: atrial septal defect; AVB: atrioventricular block; ccTGA: corrected
transposition of great arteries; CHD: congenital heart diseases; DORV: double
outlet right ventricle; LVEDD: left ventricular end diastolic diameter; LVEF: left
ventricular ejection fraction; MACE: major adverse cardiac events;
TECD: complete endocardial cushion defect; TOF: tetralogy of Fallot;
VSD: ventricular septal defect.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TZ and YWL carried out the data collection, participated in the analysis and
interpretation of clinical data, drafted the manuscript and performed the
statistical analysis. CWZ participated in the design of the study and revised
the intellectual content. HZ conceived of the study, performed all of the
surgical procedures, and helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This study was supported by Program for New Century Excellent Talents in
University, Foundation for Young Investigator at Peking Union Medical
College (XHQN09 and XR01-YP) and Foundation for Professor in PUMC.
Author details
1Department of Cardiac Surgery, Provincial Hospital Affiliated to Shandong
University, Jinan, China. 2Center for Pediatric Cardiac Surgery, National Center
for Cardiovascular Diseases and Fuwai Hospital, Beijing, China. 3Department
of Cardio-Thoracic Surgery, Shouguang People’s Hospital, Shouguang, China.
4Peking Union Medical College and Chinese Academy of Medical Sciences,
167 Beilishi Road, Beijing 100037, P.R. China.
Received: 27 January 2016 Accepted: 3 April 2016
References
1. McLeod KA. Cardiac pacing in infants and children. Heart. 2010;96:1502–8.
2. Kerstjens Frederikse MW, Bink Boelkens MT, de Jongste MJ, van der Heide
JNH. Permanent cardiac pacing in children: morbidity and efficacy of follow-
up. Int J Cardiol. 1991;33:207–14.
3. Esperer HD, Singer H, Riede FT, Blum U, Mahmoud FO, Weniger J.
Permanent epicardial and transvenous single- and dual-chamber cardiac
pacing in children. Thorac Cardiovasc Surg. 1993;41:21–7.
4. Bonatti V, Agnetti A, Squarcia U. Early and late postoperative complete
heart block in pediatric patients submitted to open-heart surgery for
congenital heart disease. Pediatr Med Chir. 1998;20:181–6.
5. Silvetti MS, Drago F, Grutter G, De Santis A, Di CV, Rava L. Twenty years of
paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292
patients. Europace. 2006;8:530–6.
6. Kwak JG, Kim SJ, Song JY, Choi EY, Lee SY, Shim WS, et al. Permanent
epicardial pacing in pediatric patients: 12-year experience at a single center.
Ann Thorac Surg. 2012;93:634–9.
7. McLeod CJ, Attenhofer JCH, Warnes CA, Hodge D, Hyberger L, Connolly
HM, et al. Epicardial versus endocardial permanent pacing in adults with
congenital heart disease. J Interv Card Electrophysiol. 2010;28:235–43.
8. Beaufort-Krol GC, Mulder H, Nagelkerke D, Waterbolk TW, Bink-Boelkens MT.
Comparison of longevity, pacing, and sensing characteristics of steroid-
eluting epicardial versus conventional endocardial pacing leads in children.
J Thorac Cardiovasc Surg. 1999;117:523–8.
9. Lotfy W, Hegazy R, AbdElAziz O, Sobhy R, Hasanein H, Shaltout F.
Permanent cardiac pacing in pediatric patients. Pediatr Cardiol.
2013;34:273–80.
10. Sachweh JS, Vazquez-Jimenez JF, Schondube FA, Daebritz SH, Dorge H,
Muhler EG, et al. Twenty years experience with pediatric pacing: epicardial
and transvenous stimulation. Eur J Cardiothorac Surg. 2000;17:455–61.
Zhang et al. Journal of Cardiothoracic Surgery  (2016) 11:61 Page 4 of 5
11. Weindling SN, Saul JP, Gamble WJ, Mayer JE, Wessel D, Walsh EP. Duration
of complete atrioventricular block after congenital heart disease surgery.
Am J Cardiol. 1998;82:525–7.
12. Epstein AE, DiMarco JP, Ellenbogen KA, Mrak Estes KA, Freedman RA, Gettes
LS. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac
Rhythm Abnormalities: a report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines (Writing
Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for
Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed
in collaboration with the American Association for Thoracic Surgery and
Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1–62.
13. Horenstein MS, Hakimi M, Walters 3rd H, Karpawich PP. Chronic performance
of steroid-eluting epicardial leads in a growing pediatric population: a 10-year
comparison. Pacing Clin Electrophysiol. 2003;26:1467–71.
14. Cohen MI, Bush DM, Vetter VL, Tanel RE, Wieand TS, Gaynor JW, et al.
Permanent epicardial pacing in pediatric patients: seventeen years of
experience and 1200 outpatient visits. Circulation. 2001;103:2585–90.
15. Janousek J, van Geldorp IE, Krupickova S, Rosenthal E, Peacock K, Tomaske
M. Permanent cardiac pacing in children: choosing the optimal pacing site:
a multicenter study. Circulation. 2013;127:613–23.
16. Gebauer RA, Tomek V, Salameh A, Marek J, Chaloupecky V, Gebauer R, et al.
Predictors of left ventricular remodelling and failure in right ventricular
pacing in the young. Eur Heart J. 2009;30:1097–104.
17. van Geldorp IE, Delhaas T, Gebauer RA, Frias P, Tomaske M, Friedberg MK, et al.
Impact of the permanent ventricular pacing site on left ventricular function in
children: a retrospective multicentre survey. Heart. 2011;97:2051–5.
18. Dodge-Khatami A, Dave H, Rahn M, Pretre R, Bauersfeld U. Left heart atrial
and ventricular epicardial pacing through a left lateral thorcacotomy in
children: a safe approach with excellent functional and cosmetic results. Eur
J Cardiothorac Surg. 2005;28:541–5.
19. Dretzke J, Toff WD, Lip GY, Raftery J, Fry-Smith A, Taylor RS. Dual chamber
versus single chamber ventricular pacemakers for sick sinus syndrome and
atrioventricular block. Cochrane Database Syst Rev. 2004;2, CD003710.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Zhang et al. Journal of Cardiothoracic Surgery  (2016) 11:61 Page 5 of 5
